Paper356975
Cell kinetics and chemotherapy: a critical review.
Tannock I. Cancer Treat Rep, 1978. Cited by 231 papers, by iCite.
Cite this record
ConductScience Library. Cell kinetics and chemotherapy: a critical review. Papers, record 356975. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356975
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Division | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Autoradiography | |
| Bone Marrow Cells | |
| Cell Cycle | |
| Clone Cells | |
| Drug Administration Schedule | |
| Humans | |
| Kinetics | |
| Leukemia | |
| Thymidine |
Source PubMed
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37790761 | Advances in hyperbaric oxygen to promote immunotherapy through modulation of the tumor microenvironment. | Front Oncol | 2023 | https://conductscience.org/library/papers/37790761 | PubMed |
| 36646904 | Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors. | Oncogene | 2023 | https://conductscience.org/library/papers/36646904 | PubMed |
| 36405317 | Synthesis, biological evaluation, and molecular docking of novel hydroxyzine derivatives as potential AR antagonists. | Front Chem | 2022 | https://conductscience.org/library/papers/36405317 | PubMed |
| 34716976 | How translational modeling in oncology needs to get the mechanism just right. | Clin Transl Sci | 2022 | https://conductscience.org/library/papers/34716976 | PubMed |
| 33228140 | A Short Review on Biomedical Applications of Nanostructured Bismuth Oxide and Related Nanomaterials. | Materials (Basel) | 2020 | https://conductscience.org/library/papers/33228140 | PubMed |
| 32799866 | CircRNAs in anticancer drug resistance: recent advances and future potential. | Mol Cancer | 2020 | https://conductscience.org/library/papers/32799866 | PubMed |
| 32049575 | The effects of proliferation status and cell cycle phase on the responses of single cells to chemotherapy. | Mol Biol Cell | 2020 | https://conductscience.org/library/papers/32049575 | PubMed |
| 31131698 | Schedule-dependent potentiation of chemotherapy drugs by the hypoxia-activated prodrug SN30000. | Cancer Biol Ther | 2019 | https://conductscience.org/library/papers/31131698 | PubMed |
| 31011405 | Spontaneous Tumor Lysis Syndrome in Childhood T cell Acute Lymphoblastic Leukemia. | Oman Med J | 2013 | https://conductscience.org/library/papers/31011405 | PubMed |
| 29799080 | The challenge of drug resistance in cancer treatment: a current overview. | Clin Exp Metastasis | 2018 | https://conductscience.org/library/papers/29799080 | PubMed |
| 29109383 | Synthesis and Antitumor Activity of Novel Arylpiperazine Derivatives Containing the Saccharin Moiety. | Molecules | 2017 | https://conductscience.org/library/papers/29109383 | PubMed |
| 28504252 | Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. | Acta Pharmacol Sin | 2017 | https://conductscience.org/library/papers/28504252 | PubMed |
| 26904687 | Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions. | Biomed Res Int | 2016 | https://conductscience.org/library/papers/26904687 | PubMed |
| 23805101 | Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. | Front Pharmacol | 2013 | https://conductscience.org/library/papers/23805101 | PubMed |
| 22160948 | Anticancer effects of 5-fluorouracil combined with warming and relieving cold phlegm formula on human breast cancer. | Chin J Integr Med | 2012 | https://conductscience.org/library/papers/22160948 | PubMed |
| 19500391 | Neoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopy. | BMC Cancer | 2009 | https://conductscience.org/library/papers/19500391 | PubMed |
| 19002794 | New insights into the kinetic resistance to anticancer agents. | Cytotechnology | 1998 | https://conductscience.org/library/papers/19002794 | PubMed |
| 18854836 | Cell cycle times of short-term cultures of brain cancers as predictors of survival. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18854836 | PubMed |
| 12915875 | DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12915875 | PubMed |
| 10455409 | Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule. | Gene Ther | 1999 | https://conductscience.org/library/papers/10455409 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/356975
GET https://conductscience.org/api/papers/v1/356975/cited_by?page=2